NASDAQ:BBIO

Bridgebio Pharma Stock Insider Trading

etoro logo Buy BBIO
*Your capital is at risk
$65.48
+1.60 (+2.50%)
At Close: Jun 03, 2026

Bridgebio Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -80.57. In total, the insiders bought 728.07K and sold 624.83K BBIO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-80.57
Buy 728.07K shares
Sell 624.83K shares
28% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Mar 18, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -80.57.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 17, 2026
Sell
Common Stock
S-Sale
Trimarchi Thomas
President And CFO
CEO / President 200
Value: $15.1K
Feb 17, 2026
Sell
Common Stock
S-Sale
Scott Randal W.
Director
Director 1 900
Value: $141.2K
Feb 17, 2026
Buy
Common Stock
M-Exempt
Scott Randal W.
Director
Director 10 000
Value: $167.5K
Feb 17, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Scott Randal W.
Director
Director 10 000
Value: $167.5K
Feb 17, 2026
Sell
Common Stock
S-Sale
Apuli Maricel
Chief Accounting Officer
Officer 510
Value: $37.9K
Feb 17, 2026
Sell
Common Stock
S-Sale
Trimarchi Thomas
President And CFO
CEO / President 13 400
Value: $1.00M
Feb 16, 2026
Buy
Common Stock
M-Exempt
Kumar Neil
Chief Executive Officer
CEO / President 11 554
Value: $756.6K
Feb 16, 2026
Buy
Common Stock
M-Exempt
Kumar Neil
Chief Executive Officer
CEO / President 19 600
Value: $1.28M
Feb 16, 2026
Sell
Common Stock
F-InKind
Kumar Neil
Chief Executive Officer
CEO / President 30 970
Value: $2.33M
Feb 16, 2026
Buy
Common Stock
M-Exempt
Kumar Neil
Chief Executive Officer
CEO / President 33 544
Value: $2.20M
Feb 16, 2026
Buy
Restricted Stock Units
M-Exempt
Kumar Neil
Chief Executive Officer
CEO / President 19 600
Value: $1.28M
Feb 16, 2026
Buy
Restricted Stock Units
M-Exempt
Kumar Neil
Chief Executive Officer
CEO / President 11 554
Value: $756.6K
Feb 16, 2026
Buy
Restricted Stock Units
M-Exempt
Kumar Neil
Chief Executive Officer
CEO / President 33 544
Value: $2.20M
Feb 16, 2026
Sell
Common Stock
F-InKind
Apuli Maricel
Chief Accounting Officer
Officer 4 349
Value: $327.3K
Feb 16, 2026
Sell
Common Stock
F-InKind
Trimarchi Thomas
President And CFO
CEO / President 18 819
Value: $1.42M
Feb 11, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 4 484
Value: $325.7K
Feb 11, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 3 716
Value: $265.5K
Feb 11, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 7 806
Value: $551.8K
Feb 11, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 3 961
Value: $290.1K
Feb 11, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 4 404
Value: $319.9K
Feb 11, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 3 775
Value: $269.8K
Feb 11, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 7 860
Value: $555.7K
Feb 10, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 5 799
Value: $419.2K
Feb 10, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 14 201
Value: $1.02M
Feb 10, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 5 960
Value: $430.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BRIDGEBIO PHARMA INC.
Bridgebio Pharma
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-car...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE